|
|
Volumn 26, Issue 3, 2011, Pages 328-329
|
|
Cardio-vascular safety of acetyl cholinesterase inhibitors in patients suffering from Alzheimer's disease; Factors that predict poor tolerability
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLCHOLINESTERASE;
CHOLINESTERASE INHIBITOR;
DONEPEZIL;
GALANTAMINE;
GALANTAMINE XL;
RIVASTIGMINE;
UNCLASSIFIED DRUG;
AGITATION;
ALZHEIMER DISEASE;
BLOOD PRESSURE MONITORING;
BRADYCARDIA;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
ECG ABNORMALITY;
ELECTROCARDIOGRAM;
FIRST DEGREE ATRIOVENTRICULAR BLOCK;
GASTROINTESTINAL SYMPTOM;
HEART ATRIUM FIBRILLATION;
HEART LEFT BUNDLE BRANCH BLOCK;
HEART RIGHT BUNDLE BRANCH BLOCK;
HEART VENTRICLE EXTRASYSTOLE;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MENTAL DISEASE;
NON SPECIFIC T WAVE ABNORMALITY;
PATIENT COMPLIANCE;
PULSE RATE;
PULSE RHYTHM;
PULSE WAVE;
SIDE EFFECT;
SUPRAVENTRICULAR PREMATURE BEAT;
SYNCOPE;
TREATMENT FAILURE;
ALZHEIMER DISEASE;
CARDIOVASCULAR DISEASES;
CHOLINESTERASE INHIBITORS;
GALANTAMINE;
HUMANS;
INDANS;
MULTIVARIATE ANALYSIS;
PHENYLCARBAMATES;
PIPERIDINES;
RETROSPECTIVE STUDIES;
|
|
EID: 79951730463
PISSN: 08856230
EISSN: 10991166
Source Type: Journal
DOI: 10.1002/gps.2487 Document Type: Letter |
|
Times cited : (2)
|
|
References (4)
|
